SANUWAVE Health, Inc. (SNWV)
NASDAQ: SNWV · Real-Time Price · USD
34.67
-1.26 (-3.51%)
At close: Jul 11, 2025, 4:00 PM
34.78
+0.11 (0.32%)
After-hours: Jul 11, 2025, 4:04 PM EDT
SANUWAVE Health Market Cap
SANUWAVE Health has a market cap or net worth of $297.56 million as of July 11, 2025.
Market Cap
297.56M
Enterprise Value
315.93M
1-Year Change
n/a
Ranking
Category
Stock Price
$34.67
Market Cap Chart
Since March 7, 2025, SANUWAVE Health's market cap has increased from $247.50M to $297.56M, an increase of 20.23%. That is a compound annual growth rate of 70.51%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 11, 2025 | 297.60M | -3.19% |
Jul 10, 2025 | 307.40M | -0.26% |
Jul 9, 2025 | 308.20M | 3.25% |
Jul 8, 2025 | 298.50M | 5.18% |
Jul 7, 2025 | 283.80M | 4.80% |
Jul 3, 2025 | 270.80M | -0.22% |
Jul 2, 2025 | 271.40M | -1.56% |
Jul 1, 2025 | 275.70M | -1.92% |
Jun 30, 2025 | 281.10M | 9.72% |
Jun 27, 2025 | 256.20M | -9.37% |
Jun 26, 2025 | 282.70M | 0.43% |
Jun 25, 2025 | 281.50M | 1.04% |
Jun 24, 2025 | 278.60M | -2.99% |
Jun 23, 2025 | 287.20M | -0.35% |
Jun 20, 2025 | 288.20M | 2.09% |
Jun 18, 2025 | 282.30M | 10.40% |
Jun 17, 2025 | 255.70M | -3.44% |
Jun 16, 2025 | 264.80M | 4.21% |
Jun 13, 2025 | 254.10M | -4.15% |
Jun 12, 2025 | 265.10M | -1.23% |
Jun 11, 2025 | 268.40M | 1.71% |
Jun 10, 2025 | 263.90M | 2.29% |
Jun 9, 2025 | 258.00M | 8.04% |
Jun 6, 2025 | 238.80M | 0.42% |
Jun 5, 2025 | 237.80M | 2.94% |
View and export this data all the way back to 2025.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 706.45B |
Johnson & Johnson | 376.02B |
AbbVie | 336.71B |
Novo Nordisk | 308.58B |
UnitedHealth Group | 274.78B |
Novartis AG | 240.09B |
Abbott Laboratories | 231.78B |
AstraZeneca | 218.25B |